Abstract
Currently, fluorine-18 labeled fluorodeoxyglucose (FDG), a glucose analogue, is the most commonly used imaging agent for positron emission tomography (PET) in cancer patients. The excellent clinical information obtained by the FDG PET has made it essential in the management of many cancers. Despite its proven clinical utilities, FDG PET has some well known limitations. Several other agents for PET imaging have been developed, which can overcome certain limitations of FDG, provide new information on the biologic, metabolic and molecular characteristics of malignant tumors, and aid in the diagnosis, optimal therapeutic approach, prognostic assessment and therapy monitoring in cancer patients. This review focuses on the biological basis of cancer imaging with some PET imaging agents, other than FDG, and their potential clinical applications. Emphasis is given to 1) choline, a precursor of cell membrane phospholipids, 2) acetate, an intermediate of lipid metabolism, 3) methionine, an essential amino acid, 4) fluorothymidine, a nucleoside analog and marker of cellular proliferation, and 5) fluoromisonidazole, a nitroimidazole derivative and marker of hypoxia.
Keywords: Positron emission tomography, imaging agent, cancer imaging
Call for Papers in Thematic Issues
Advancements and Applications of Photon Counting CT: Transforming Imaging Precision and Quantification
Photon Counting Computed Tomography (CT) represents a transformative advancement in medical imaging technology, offering unprecedented levels of precision and diagnostic capability. This special issue will explore the latest innovations and applications of photon counting CT, highlighting its advantages over traditional energy-integrating detectors. The scope includes an in-depth examination of its ...read more
AI-Driven Diagnostics in Radiology and Medical Imaging
Medical imaging data, such as X-rays, MRIs, ultrasounds, CT scans, and DXAs, can be analysed by AI algorithms to help healthcare professionals identify and diagnose diseases more rapidly and accurately. Among the most cutting-edge applications of artificial intelligence (AI) in healthcare are imaging-related applications like cancer detection. AI could revolutionise ...read more
Applying medical image processing techniques for early cancer detection in mammograms
Breast cancer survival and successful treatment are significantly boosted by early identification. Breast cancer screening is most commonly accomplished with mammography. The radiologist's experience and the image quality, among several other factors, might affect how well a mammogram is interpreted. Enhancing mammography analysis and increasing cancer early detection are made ...read more
Deep Learning Approaches for Image Enhancement in Medical Diagnostics
The medical and healthcare sectors are very different from one another. Consumers in these sectors need more affordable offerings. Health or medical specialists are typically the ones who analyze medical data. In particular, medical imaging evaluation heavily relies on machine learning and deep learning. They not only yield outstanding outcomes ...read more
5
